US5086002A - Erythrocyte agglutination assay - Google Patents

Erythrocyte agglutination assay Download PDF

Info

Publication number
US5086002A
US5086002A US07/324,500 US32450089A US5086002A US 5086002 A US5086002 A US 5086002A US 32450089 A US32450089 A US 32450089A US 5086002 A US5086002 A US 5086002A
Authority
US
United States
Prior art keywords
erythrocyte
analyte
binding molecule
binding
antibody
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
US07/324,500
Inventor
Carmel J. Hillyard
Dennis B. Rylatt
Bruce E. Kemp
Peter G. Bundesen
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Agen Biomedical Ltd
Original Assignee
Agen Biomedical Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority to AUPI440087 priority Critical
Priority to AUPI4400 priority
Priority to AUPI501887 priority
Priority to AUPI5018 priority
Application filed by Agen Biomedical Ltd filed Critical Agen Biomedical Ltd
Priority to US07/324,500 priority patent/US5086002A/en
Assigned to AGEN BIOMEDICAL, LTD. reassignment AGEN BIOMEDICAL, LTD. ASSIGNMENT OF ASSIGNORS INTEREST. Assignors: KEMP, BRUCE E., BUNDESEN, PETER G., HILLYARD, CARMEL J., RYLATT, DENNIS B.
Application granted granted Critical
Publication of US5086002A publication Critical patent/US5086002A/en
Anticipated expiration legal-status Critical
Application status is Expired - Lifetime legal-status Critical

Links